Evaluation of Antidepressant-Like Activity of Solvent Partitioned Fractions of Olax subscorpioidea Oliv. (Olacaceae) Leaf Extract in Rodents http://www.doi.org/10.26538/tjnpr/v7i6.25

Main Article Content

Olusegun A. Adeoluwa
Isaiah O. Agboola
Elizabeth T. Akinluyi
Gladys O. Adeoluwa
Adegbuyi O. Aderibigbe

Abstract

Olax subscorpioidea is a medicinal plant with a long history in traditional medicine for the treatment of mental illness in Nigeria. The current study investigated antidepressant-like activity of solvent partitioned fractions. The crude extract was partitioned in increasing order of polarity to yield ethyl-acetate fraction (EAF), butanol fraction (BF) and aqueous fraction (AF). They were evaluated for antidepressant activity at doses of 5-20 mg/kg in mice using the forced swim test, tail suspension and reserpine tests. The BF, the most active was adsorbed on silica gel and subjected to vacuum liquid chromatography to yields several fractions which were subsequently pooled into five sub-fractions, F1-F5 and screened for antidepressant action. F1 being the most active one was subjected to column chromatography with n-hexane, dichloromethane and ethylacetate. The yields of twenty-six fractions were pooled into four fractions f1-f4 and were screened with the FST and TST only. The EAF, BF, F1, f1, f2, f3 and f4 fractions significantly (P<0.05) reduced immobility in the FST and TST without locomotor effect. The BF and F1 significantly (P<0.05) reversed reserpine-induced hypothermia. From the data obtained, it was observed that among all the fractions, BF, F1, f1, f2, f3 and f4 possess prominent antidepressant-like and antiimmobility effects in both FST and TST. This activity increases as the extract and fractions were further separated. This shows that the plant may have important phytochemicals with great potential for the development of a new antidepressant, thus justifying the traditional use of the plant in mental illness.

Article Details

How to Cite
Adeoluwa, O. A., Agboola, I. O., Akinluyi, E. T., Adeoluwa, G. O., & Aderibigbe, A. O. (2023). Evaluation of Antidepressant-Like Activity of Solvent Partitioned Fractions of Olax subscorpioidea Oliv. (Olacaceae) Leaf Extract in Rodents: http://www.doi.org/10.26538/tjnpr/v7i6.25. Tropical Journal of Natural Product Research (TJNPR), 7(6), 3230-3235. https://tjnpr.org/index.php/home/article/view/2109
Section
Articles

References

Ibrahim JA, Muazzam I, Jegede IA, Kunle OF, Okogun JI. Ethno-medicinal plants and methods used by Gwandara tribe of Sabo Wuse in Niger State, Nigeria, to treat mental illness. Afr. J. of Trad. Compl. and Alt. Med. 2007; 4(2): 211-218.

Onyeabor A, Onoja SO, Uwalaka EC, Obi CF, Eze, BO. Investigation of the Antitrypanosomal Activity of Hydromethanol Extract of Olax subscorpioidea Root in Rats Experimentally Infected with Trypanosoma brucei. Trop J Nat Prod Res.2022; 6(4):650- 653.doi.org/10.26538/tjnpr/v6i4.29.

Soladoye MO, Amusa NA, Raji-Esan SO, Chuckwuma EC, Taiwo AA. Ethnobotanical survey of anti-cancer plants in Ogun state, Nigeria. Ann. Biol. Res. 2010; 1:261-273.

Odoma S, Zezi AU, Danjuma MN, Abubakar A, Magaji GM.Effects of Aqueous and Butanol Leaf Fractions of Olax subscorpioidea Oliv. on Inflammatory Cytokines in Wistar Rats. Trop J Nat Prod Res. 2020; 4(9):606- 611.doi.org/10.26538/tjnpr/v4i9.19

Ishola IO, Akinyede A, Lawal SW, Popoola TD, Lawal AM. Antinociceptive and anti-inflammatory effects of Olax subscorpioidea Oliv. (Olacaceae) leaf extract in rodents: possible mechanisms of antinociceptive action. West Afr. J. of Pharm. 2015; 26: 99-112.

Adeoluwa OA, Aderibigbe AO, Agu GO. Pharmacological Evaluation of Central Nervous System Effects of Ethanol Leaf Extract of Olax subscorpioidea in Experimental Animals. Drug Res (Stuttg). 2016; 66(4): 203-10.

Adeoluwa OA, Aderibigbe AO, Bakre AG. Evaluation of Antidepressant-like Effect of Olax subscorpioidea Oliv. (Olacaceae) Extract in Mice. Drug Res (Stuttg). 2015; 65(6): 306-11.

Adegbite OS, Akinsaya YI, Kukoyi AJ, Iyanda-Joel WO, Daniel OO, Adebayo AH. Induction of rat hepatic mitochondrial membrane permeability transition pore opening by leaf extract of Olax subscorpioidea. Pharmacog. Res. 2015; 7: S63-68.

Oyedeapo OO, Famurewa AJ. Antiprotease and membrane stabilizing activities of extracts of Fagara zanthoxyloides, Olax subscorpioidea and Tetrapleura tetraptera. Int. J. Pharmacog.1995; 33: 65-69.

Ayandele AA, Adebiyi AO. The phytochemical analysis and antimicrobial screening of extracts of Olax subscorpioidea. Afr. J. of Biotechnol. 2007; 6(7): 868-870.

Kazeem MI, Ayeleso OA, Mukwevho E. Olax subscorpioidea Oliv. Leaf alleviates postprandial hyperglycaemia by inhibition of alpha-amylase and alphaglucosidase. Int. J. of Pharmacol. 2015; 11: 484-489.

Ke F, Li HR, Chen XX, Gao XR, Huang LL, Du AQ, Jiang C, Li H, Ge JF, Quercetin alleviates LPS-induced depression-like behavior in rats via regulating BDNF-related imbalance of copine 6 and TREM1/2 in the hippocampus and PFC, Front. Pharmacol. 2020; 1–13.

https://doi.org/10.3389/fphar.2019.01544.

Adeoluwa AO, Aderibigbe OA, Agboola IO, Olonode TE, Ben-Azu B. Butanol Fraction of Olax Subscorpioidea Produces Antidepressant Effect: Evidence for the Involvement of Monoaminergic Neurotransmission. Drug Res (Stuttg). 2019; 69(1):53-60. https://doi.org/10.1055/a- 0651-7939

Kraeuter AK, Guest PC, Sarnyai Z. The Open Field Test for Measuring Locomotor Activity and Anxiety-Like Behavior, Methods. Mol. Biol. 2019; 1916: 99–103. https://doi.org/10.1007/978-1-4939-8994-2_9.

Bakre AG, Odusanya ST, Olowoparija SF, Ojo OR, Olayemi JO, Aderibigbe AO. Behavioral and biochemical evidences for antidepressant activity of ethanol extract of Jatropha curcas in mice subjected to chronic unpredictable mild stress. J. of Biol. and Nature. 2020; 11(1): 1-10.

Li Y, Yao J, Han C, Yang J, Chaudhry MT, Wang S, Liu H, Yin Y. Quercetin, inflammation and immunity, Nutr. 2016; 8 https://doi.org/10.3390/nu8030167.

An L, Zhang YZ, Yu NJ et al. “Role for serotonin in the antidepressant-like effect of a flavonoid extract of Xiaobuxin-Tang,” Pharmacol. Biochem. and Behav. 2008; 89:572–580.

Bourin M, Fiocco AJ, Clenet F. How valuable are animalmodels in defining antidepressant activity? Hum. Psychopharmacol. 2001; 6: 9–21.

Takahashi E, Katayama M, Nimii K, Itakura C. Additive sub threshold dose effects of cannabinoid CB1 receptor antagonist and selective serotonin re-uptake inhibitor in antidepressant behavioral tests. Euro. J. Pharmacol. 2008; 589: 149–156. Borsini F, Meli A. Is the forced swimming test a suitable

model for revealing antidepressant activity? Psychopharmacol. 1988; 94: 147-160.